| # | Drug | Count |
|---|---|---|
| 0 | LITHIUM | 13 |
| 1 | LITHIUM BROMATUM | 13 |
| 2 | ARIPIPRAZOLE | 11 |
| 3 | ARIPIPRAZOLE ORAL | 9 |
| 4 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 9 |
| 5 | CETIRIZINE HYDROCHLORIDE | 9 |
| 6 | CLOZAPINE | 9 |
| 7 | OMEPRAZOLE | 9 |
| 8 | OMEPRAZOLE MAGNESIUM | 9 |
| 9 | BISACODYL | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARIDOREXANT | 8 | 0.0029 |
| 1 | LOXAPINE | 6 | 0.0015 |
| 2 | BISACODYL SUPPOSITORIES | 8 | 0.0006 |
| 3 | BISCODYL | 8 | 0.0006 |
| 4 | BISACODYL | 8 | 0.0006 |
| 5 | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | 2 | 0.0006 |
| 6 | LITHIUM | 13 | 0.0005 |
| 7 | ATAZANAVIR | 5 | 0.0003 |
| 8 | RITONAVIR 100 MG | 5 | 0.0003 |
| 9 | SENNOSIDES 8.6 MG TABLETS | 6 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Stimulant Laxative [EPC] | 8 | 0.0006 |
| 1 | Orexin Receptor Antagonist [EPC] | 8 | 0.0004 |
| 2 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 7 | 0.0001 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 6 | Atypical Antipsychotic [EPC] | 21 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 8 | Macrolide Antimicrobial [EPC] | 2 | 0.0000 |
| 9 | Anti-epileptic Agent [EPC] | 7 | 0.0000 |